ATE141798T1 - Medizinische verwendung von neuropeptid antagonist g - Google Patents

Medizinische verwendung von neuropeptid antagonist g

Info

Publication number
ATE141798T1
ATE141798T1 AT89904170T AT89904170T ATE141798T1 AT E141798 T1 ATE141798 T1 AT E141798T1 AT 89904170 T AT89904170 T AT 89904170T AT 89904170 T AT89904170 T AT 89904170T AT E141798 T1 ATE141798 T1 AT E141798T1
Authority
AT
Austria
Prior art keywords
oligopeptides
medical use
neuropeptides
antagonist
neuropeptide antagonist
Prior art date
Application number
AT89904170T
Other languages
English (en)
Inventor
Enrique Rozengurt
Penella Woll
Original Assignee
Imp Cancer Res Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp Cancer Res Tech filed Critical Imp Cancer Res Tech
Application granted granted Critical
Publication of ATE141798T1 publication Critical patent/ATE141798T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT89904170T 1988-03-21 1989-03-21 Medizinische verwendung von neuropeptid antagonist g ATE141798T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888806644A GB8806644D0 (en) 1988-03-21 1988-03-21 Neuropeptide antagonists

Publications (1)

Publication Number Publication Date
ATE141798T1 true ATE141798T1 (de) 1996-09-15

Family

ID=10633786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89904170T ATE141798T1 (de) 1988-03-21 1989-03-21 Medizinische verwendung von neuropeptid antagonist g

Country Status (6)

Country Link
EP (1) EP0406297B1 (de)
JP (2) JP2818679B2 (de)
AT (1) ATE141798T1 (de)
DE (1) DE68927048T2 (de)
GB (1) GB8806644D0 (de)
WO (1) WO1989009232A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215963A (en) * 1989-10-24 1993-06-01 Berlex Laboratories, Inc. Solubilization and purification of the active gastrin releasing peptide receptor
US5834433A (en) * 1990-07-26 1998-11-10 Merrell Pharmaceuticals Inc. Compounds and pharmaceutical uses of peptides of bombesin and GRP
AU1793092A (en) * 1991-03-15 1992-10-21 Berlex Laboratories, Inc. Receptors for bombesin-like peptides
AU659659B2 (en) * 1991-05-23 1995-05-25 Merrell Dow Pharmaceuticals Inc. Bombesin analogs
JPH07505865A (ja) * 1992-02-07 1995-06-29 メレルダウファーマスーティカルズ　インコーポレイテッド ボンベシンのフェニルアラニン類似体類
DE60032822T2 (de) * 2000-07-31 2007-11-08 Dabur Pharma Ltd., New Delhi Analoge der substanz p zur behandlung von krebs
US6596692B1 (en) 2000-07-31 2003-07-22 Dabur Research Foundation Substance P analogs for the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE110390T1 (de) * 1987-03-31 1994-09-15 Imp Cancer Res Tech Wachstumsfaktor-rezeptor.

Also Published As

Publication number Publication date
JPH04501556A (ja) 1992-03-19
WO1989009232A1 (en) 1989-10-05
GB8806644D0 (en) 1988-04-20
DE68927048T2 (de) 1997-04-03
EP0406297B1 (de) 1996-08-28
DE68927048D1 (de) 1996-10-02
EP0406297A1 (de) 1991-01-09
JP2818679B2 (ja) 1998-10-30
JPH1171298A (ja) 1999-03-16

Similar Documents

Publication Publication Date Title
ATE11372T1 (de) Von vernetztem fibrin abgeleitete radiomarkierte peptide zur bestimmung von thrombi und die dieselben enthaltenden injektierbaren zusammensetzungen.
DE69229911D1 (de) Monoklonale antikörper gegen rezeptor-induzierte bindungsstellen
DE69942753D1 (de) Peptidantagonist von Zonulin und dessen Verwendung
ES2059547T3 (es) Expresion y secrecion mejoradas de proteinas heterologas en levadura, empleando secuencia conductora de factor alfa truncado.
DK0429626T3 (da) Syntetiske peptider til påvisning af thromber
DK0912738T3 (da) Antigen-bindende-fragmenter der specifikt detekterer cancerceller, nukleotider der koder fragmenterne og anvendelse deraf til profylakse og detektion af cancere
DE69228701D1 (de) Fragmente von Prion Proteinen.
ATE235510T1 (de) Integrinbindendes peptid und dessen verwendung
AU1873992A (en) Bradykinin antagonist peptides
DE68927048D1 (de) Medizinische Verwendung von neuropeptid Antagonist G
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
DE69331501D1 (de) Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin
DE68925199D1 (de) Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke
ES2123556T3 (es) Peptidos de tipo bradiquinina.
ATE161543T1 (de) Aminoterminale prokollagen 1(i) peptide
ES2185630T3 (es) Nuevos polipeptidos y peptidos, acidos nucleicos que los codifican, y su utilizacion en el campo de la terapia de tumores, inflamacion o inmunologia.
DE69122103D1 (de) Antigerinnungspeptide
EA200001127A1 (ru) Бактериальные феромоны и их использование
DE69434151D1 (de) Therapeutische inhaltsstoffe
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
ATE180788T1 (de) Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide
DE2965929D1 (en) Ovulation enhancing peptides and their pharmaceutical compositions
DE69003216D1 (de) Verwendung von somatostatin.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties